3 stories mentioning HKG:0882Updated 12d ago
Every FINWIRES story that references HKG:0882, newest first.
Tianjin Development Holdings (HKG:0882) Chairman Teng Fei resigned as chairman and executive director, effective Friday, due to other business engagements, according to a same-day Hong Kong bourse filing.The company appointed Zhang Wang as chairman and executive director.
Tianjin Lisheng Pharmaceutical (SHE:002393) expects attributable net profit of 730 million yuan to 830 million yuan for the first half of 2026, down 76% to 79% from 3.43 billion yuan in the year-earlier period, according to a Wednesday Hong Kong bourse filing by parent Tianjin Development (HKG:0882).Basic earnings per share are expected to range between 0.23 yuan and 0.28 yuan, compared with 1.11 yuan a year earlier.The company attributed the expected decline to a higher comparison base from dividends received from Tasly Group in the prior-year period, as well as lower revenue and profit resulting from centralized, volume-based pharmaceutical procurement and product price reductions.
Tianjin Lisheng Pharmaceutical (SHE:002393) booked 51.9 million yuan in attributable profit for the first quarter of 2026, falling from 55.3 million yuan in the prior-year period, according to a Friday Hong Kong bourse filing by parent Tianjin Development (HKG:0882).Shares of the company dropped nearly 6% in morning trade Friday.Earnings per share were 0.20 yuan, compared with 0.21 yuan a year earlier.Total operating income fell to 332.3 million yuan from 369.8 million yuan in the comparable, year-ago period.
